LACTOSOLV Trademark

Trademark Overview

On Thursday, December 19, 2013, a trademark application was filed for LACTOSOLV with the United States Patent and Trademark Office. The USPTO has given the LACTOSOLV trademark a serial number of 79143839. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Tuesday, December 19, 2023. This trademark is owned by SCIOTEC Diagnostic Technologies GmbH. The LACTOSOLV trademark is filed in the Pharmaceutical Products category with the following description:

Medical preparations, namely, lactase enzymes for medical purposes; medicines for human purposes, namely, medicines consisting primarily of lactase enzymes for the treatment of lactose intolerance; all aforementioned goods excluding pharmaceutical preparations and preparations for the treatment of renal insufficiency; nutritional supplements consisting primarily of lactase enzymes
lactosolv

General Information

Serial Number79143839
Word MarkLACTOSOLV
Filing DateThursday, December 19, 2013
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateTuesday, December 19, 2023
Registration Number4686369
Registration DateTuesday, February 17, 2015
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 2, 2014

Trademark Statements

Goods and ServicesMedical preparations, namely, lactase enzymes for medical purposes; medicines for human purposes, namely, medicines consisting primarily of lactase enzymes for the treatment of lactose intolerance; all aforementioned goods excluding pharmaceutical preparations and preparations for the treatment of renal insufficiency; nutritional supplements consisting primarily of lactase enzymes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, September 3, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSTADA Arzneimittel AG
Party Type31 - New Owner After Registration
Legal Entity Type98 - Unknown
AddressDE
Party NameSCIOTEC Diagnostic Technologies GmbH
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressA-3430 Tulln
AT
Party NameSCIOTEC Diagnostic Technologies GmbH
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressA-3430 Tulln
AT
Party NameSCIOTEC Diagnostic Technologies GmbH
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressA-3430 Tulln
AT

Trademark Events

Event DateEvent Description
Friday, March 14, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 18, 2014APPLICATION FILING RECEIPT MAILED
Friday, March 21, 2014ASSIGNED TO EXAMINER
Thursday, March 13, 2014SN ASSIGNED FOR SECT 66A APPL FROM IB
Wednesday, March 26, 2014NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, September 24, 2014TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 25, 2014NON-FINAL ACTION WRITTEN
Wednesday, March 26, 2014NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, March 26, 2014REFUSAL PROCESSED BY MPU
Friday, April 11, 2014REFUSAL PROCESSED BY IB
Thursday, May 8, 2014CORRECTION TRANSACTION RECEIVED FROM IB
Friday, May 16, 2014CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
Friday, August 22, 2014NEW REPRESENTATIVE AT IB RECEIVED
Wednesday, October 15, 2014EXAMINER'S AMENDMENT ENTERED
Wednesday, September 24, 2014TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, September 24, 2014ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, September 24, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, September 25, 2014ASSIGNED TO LIE
Saturday, October 4, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, October 4, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 15, 2014EXAMINERS AMENDMENT -WRITTEN
Wednesday, October 15, 2014EXAMINERS AMENDMENT E-MAILED
Wednesday, October 15, 2014NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, November 12, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 2, 2014PUBLISHED FOR OPPOSITION
Tuesday, December 2, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 17, 2015REGISTERED-PRINCIPAL REGISTER
Sunday, May 17, 2015FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Wednesday, July 1, 2015FINAL DISPOSITION PROCESSED
Monday, October 27, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, October 27, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, April 3, 2015CORRECTION TRANSACTION RECEIVED FROM IB
Tuesday, April 14, 2015CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
Wednesday, July 1, 2015FINAL DISPOSITION NOTICE SENT TO IB
Friday, July 17, 2015FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, July 28, 2016NEW REPRESENTATIVE AT IB RECEIVED
Thursday, December 29, 2016CHANGE OF OWNER RECEIVED FROM IB
Monday, February 17, 2020COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, June 4, 2021NEW REPRESENTATIVE AT IB RECEIVED
Friday, September 3, 2021CANCELLED SECTION 71
Tuesday, May 3, 2022TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Wednesday, August 3, 2022INVALIDATION PROCESSED
Wednesday, August 3, 2022TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Sunday, August 28, 2022TOTAL INVALIDATION PROCESSED BY THE IB
Monday, July 8, 2024DEATH OF INTERNATIONAL REGISTRATION
Monday, July 8, 2024NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED

Related Keywords

lactosolv lactase preparations enzymes primarily medical consisting treatment purposes namely medicines